Clinical Trial Results: Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating peptide-coupled red blood cells for relapsing-remitting multiple sclerosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Peptide-coupled Red Blood Cells (peptide-coupled red blood cells)

Snippet

Sponsor: Cellerys AG | Conditions: Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 1 | Status: COMPLETED | Results posted: 2026-06-08